Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Cardiovascular Research Institute Basel, Department of Cardiology, University Hospital Basel, University Basel, Basel, Switzerland.
Heart. 2019 Sep;105(18):1423-1431. doi: 10.1136/heartjnl-2018-314305. Epub 2019 Apr 24.
Assess the relative incidence and compare characteristics and outcome of unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI).
Two independent prospective multicentre diagnostic studies (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] and High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome [High-STEACS]) enrolling patients with acute chest discomfort presenting to the emergency department. Central adjudication of the final diagnosis was done by two independent cardiologists using all clinical information including serial measurements of high-sensitivity cardiac troponin (hs-cTn). All-cause death and future non-fatal MI were assessed at 30 days and 1 year.
8992 patients were enrolled at 11 centres. UA was adjudicated in 8.9%(95% CI 8.0 to 9.7) and 2.8% (95% CI 2.3 to 3.3) patients in APACE and High-STEACS, respectively, and NSTEMI in 15.1% (95% CI 14.0 to 16.2) and 13.4% (95% CI 12.4 to 14.3). Coronary artery disease was pre-existing in 73% and 76% of patients with UA. At 30 days, all-cause mortality in UA was substantially lower as compared with NSTEMI (0.5% vs 3.7%, p=0.002 in APACE, 0.7% vs 7.4%, p=0.004 in High-STEACS). Similarly, at 1 year in UA all-cause mortality was 3.3% (95% CI 1.2 to 5.3) vs 10.4% (95% CI 7.9 to 12.9) in APACE, and 5.1% (95% CI 0.7 to 9.5) vs 22.9% (95% CI 19.3 to 26.4) in High-STEACS, and similar to non-cardiac chest pain (NCCP). In contrast, future non-fatal MI in APACE was comparable in UA and NSTEMI (11.2%, 95% CI 7.8 to 14.6 and 7.9%, 95% CI 5.7 to 10.2), and higher than in NCCP (0.6%, 95% CI 0.2 to 1.0).
The relative incidence and mortality of UA is substantially lower than that of NSTEMI, while the rate of future non-fatal MI is similar.
评估不稳定型心绞痛(UA)和非 ST 段抬高型心肌梗死(NSTEMI)的相对发生率,并比较其特征和结局。
两项独立的前瞻性多中心诊断研究(优势预测急性冠状动脉综合征评估 [APACE] 和高敏肌钙蛋白在急性冠状动脉综合征患者评估中的应用 [High-STEACS])纳入了因急性胸痛就诊于急诊科的患者。两名独立的心脏病专家根据所有临床信息(包括高敏肌钙蛋白 [hs-cTn] 的连续测量值)对最终诊断进行中心裁决。所有原因死亡和未来非致命性 MI 在 30 天和 1 年时进行评估。
在 11 个中心共纳入了 8992 名患者。UA 的发生率分别为 APACE 研究中的 8.9%(95%CI 8.0 至 9.7)和 High-STEACS 研究中的 2.8%(95%CI 2.3 至 3.3),NSTEMI 的发生率分别为 15.1%(95%CI 14.0 至 16.2)和 13.4%(95%CI 12.4 至 14.3)。73%和 76%的 UA 患者存在预先存在的冠状动脉疾病。在 30 天,UA 的全因死亡率明显低于 NSTEMI(APACE 研究中 0.5% vs 3.7%,p=0.002;High-STEACS 研究中 0.7% vs 7.4%,p=0.004)。同样,在 1 年时,UA 的全因死亡率在 APACE 研究中为 3.3%(95%CI 1.2 至 5.3),而 NSTEMI 为 10.4%(95%CI 7.9 至 12.9),在 High-STEACS 研究中为 5.1%(95%CI 0.7 至 9.5),而 NCCP 为 22.9%(95%CI 19.3 至 26.4)。与非心源性胸痛(NCCP)相比,UA 的未来非致命性 MI 发生率相似。相反,APACE 研究中 UA 和 NSTEMI 的未来非致命性 MI 发生率相似(11.2%,95%CI 7.8 至 14.6 和 7.9%,95%CI 5.7 至 10.2),高于 NCCP(0.6%,95%CI 0.2 至 1.0)。
UA 的相对发生率和死亡率明显低于 NSTEMI,而未来非致命性 MI 的发生率相似。